Beerse, Belgium

Albert Louis Anna Willemsens


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Inventive Contributions of Albert Louis Anna Willemsens

Introduction: Albert Louis Anna Willemsens, a distinguished inventor based in Beerse, Belgium, has made significant strides in the field of pharmaceuticals. His inventive work focuses on innovative processes related to drug development, showcasing his dedication to advancing medical therapies.

Latest Patents: Willemsens holds one notable patent, which pertains to the resolution of (±)-methyl phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate. This invention aims to isolate the MTP (microsomal triglyceride transfer protein) inhibitor methyl (2S)-phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate. Additionally, it includes an epimerisation procedure for racemizing methyl (2R)-phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate. This innovative resolution process reflects Willemsens' commitment to enhancing therapeutic options.

Career Highlights: Willemsens currently works at Janssen Pharmaceutica NV, a leading pharmaceutical company known for its role in developing innovative health solutions. His work has significantly contributed to the company's research endeavors, particularly in the area of drug formulation and development.

Collaborations: Throughout his career, Willemsens has collaborated with esteemed colleagues, including Alex Herman Copmans and Jérôme Albert Joseph Hoet. These partnerships have fostered a collaborative environment that has been instrumental in driving forward innovative projects within the pharmaceutical sector.

Conclusion: Albert Louis Anna Willemsens represents a remarkable figure in the realm of pharmaceutical innovation, with his patent highlighting a crucial advancement in therapeutic development. His work at Janssen Pharmaceutica NV, along with his collaborations with industry colleagues, positions him as a key contributor to significant advancements in medical science. As innovations continue to evolve, Willemsens’ contributions will undoubtedly have a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…